Valuation: Celltrion, Inc.

Market Cap 41,712B 31.08B 27.61B 25.74B 23.48B 44.26B 2,992B 44.67B 312B 121B 1,526B 117B 114B 4,918B P/E 2026 *
27.6x
P/E 2027 * 23.7x
Enterprise Value 43.91B 32.71M 29.07M 27.09M 24.72M 46.59M 3.15B 47.03M 329M 127M 1.61B 123M 120M 5.18B EV / Sales 2026 *
7.93x
EV / Sales 2027 * 6.78x
Free-Float
60.59%
Yield 2026 *
0.41%
Yield 2027 * 0.43%
1 day-0.54%
1 week+2.93%
Current month+2.76%
1 month-2.87%
3 months+4.64%
6 months-6.93%
Current year+5.93%
1 week 175,500
Extreme 175500
184,200
1 month 174,600
Extreme 174600
191,100
Current year 158,500
Extreme 158500
239,047.62
1 year 158,500
Extreme 158500
239,047.62
3 years 114,250.83
Extreme 114250.828535
239,047.62
5 years 114,250.83
Extreme 114250.828535
239,047.62
10 years 64,487.59
Extreme 64487.593381
325,235.48
Manager TitleAgeSince
Chief Executive Officer 65 2015-03-19
Chief Executive Officer 42 2021-03-25
President 51 2026-02-12
Director TitleAgeSince
Chairman 69 -
Director/Board Member 61 2005-03-31
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
1/16/26 Sell 500 0.0002%
1/16/26 Sell 1,000 0.0004%
1/16/26 Sell 1,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.54%+2.93%+9.50%+50.41% 30.77B
+4.16%+3.04%+49.37%+94.17% 74.41B
-3.11%-2.32%+23.28%+77.03% 59.26B
+0.89%-0.77%+5.80%+32.89% 47.14B
-0.96%-6.11%+26.70%+31.24% 42.91B
+0.36%+3.39%+350.59%+646.53% 44.13B
-0.20%-0.53%+6.84%+99.07% 40.79B
-2.68%+5.11%+33.11%+19.50% 29.31B
+2.33%-8.58%-24.55%+340.08% 23.71B
+0.05%-2.38%-5.20%-10.81% 24.33B
Average +0.03%-0.82%+47.54%+138.01% 41.68B
Weighted average by Cap. +0.23%-0.52%+54.65%+136.67%

Financials

2026 *2027 *
Net sales 5,535B 4.12B 3.66B 3.42B 3.12B 5.87B 397B 5.93B 41.42B 16.06B 202B 15.48B 15.14B 653B 6,350B 4.73B 4.2B 3.92B 3.57B 6.74B 455B 6.8B 47.51B 18.42B 232B 17.75B 17.37B 749B
Net income 1,538B 1.15B 1.02B 949M 866M 1.63B 110B 1.65B 11.51B 4.46B 56.24B 4.3B 4.21B 181B 1,780B 1.33B 1.18B 1.1B 1B 1.89B 128B 1.91B 13.32B 5.16B 65.1B 4.98B 4.87B 210B
Net Debt 2,198B 1.64B 1.45B 1.36B 1.24B 2.33B 158B 2.35B 16.44B 6.38B 80.38B 6.14B 6.01B 259B 1,318B 982M 873M 813M 742M 1.4B 94.54B 1.41B 9.86B 3.82B 48.21B 3.69B 3.61B 155B
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,956
Date Price Change Volume
26-10-02 ₩182,600.00 -0.54% 319,980
26-10-01 ₩183,600.00 +3.32% 422,088
26-09-30 ₩177,700.00 -0.67% 352,051
26-09-29 ₩178,900.00 +0.34% 298,374
26-09-28 ₩178,300.00 +0.51% 267,873
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
182,600.00KRW
Average target price
267,741.48KRW
Spread / Average Target
+46.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A068270 Stock